Type 2 Diabetes mellitus T2DM has been suggested to be the most common
metabolic disorder associated with magnesium deficiency which has many adverse
outcomes. The aim of this study was to evaluate plasma Mg in 126 T2DM patients
recruited from Dia
betes Centre in Lattakia, compare them to 70 healthy individuals, and
assess the correlation between plasma Mg and HbA1c as a glycemic control biomarker.
Magnesium was measured using xylidyl blue colorimetric method. HbA1c was measured
using ion-exchange resin separation. The SPSS 19.0 software was used for statistical
analysis. Mean plasma Mg concentrations of the diabetics was significantly lower than
controls (P=0.0001). Plasma magnesium was negatively correlated with HbA1c (r=-0.5,
P=0.0002). Plasma magnesium was below the normal reference range (1.9-2.5 mg/dL) in
47.6% of diabetics and 28.6% of controls. In conclusion, it is important to monitor Mg
levels in both T2DM patients and non-diabetics and take procedures to correct
hypomagnesaemia states.
This study tries to assess the potential anti-atherosclerotic role of adiponectin. It includes 54 patients at Al-Assad University Hospital in Lattakia, who are candidates for catheterization, and control group of 25 individuals.
Serum adiponectin
levels have been measured in both groups, and levels of hs-CRP have been also measured in both groups and compared with adiponectin levels. Catheterization has been done to the patients group and the results of angiography are categorized to mild, moderate, and severe coronary artery disease (CAD) according to the SYNTAX SCORE
The study concludes that serum adiponectin levels are higher in patients with mild CAD(23.86 μg/ml) compared to patients with moderate to severe CAD (13.62 μg/ml);(p=0.001<0.05). The average serum adiponectin levels in control group was (17.1μg/ml). There was no statistically significant of the relation between the concentration of hs-CRP and the concentration of adiponectin .However, there was a statistically significant difference between the average concentration of hs-CRP in the patients group (7.1 mg/l) and the control group (2.7 mg/l); (P=0.003<0.05).
Background: Diabetes mellitus type2 (T2DM) and thyroid dysfunction (TD) are the
two most common endocrine disorders in clinical practice. The unrecognized TD may
adversely affect the metabolic control and add more risk to an already predisposing
s
cenario for cardiovascular diseases. The objective of this study was to investigate the
prevalence of TD in patients with type2 diabetes mellitus.
Objective: To determine the prevalence and patterns of thyroid dysfunction in
patients with type2 diabetes mellitus.
Material and methods: Study included total 362 subjects (204 type2 diabetic patients
and 158 healthy non diabetic subjects). Agroup of type2 diabetic patients and control group
were evaluated for thyroid dysfunction by testing TSH and FT4 when TSH was abnormal.
The correlation of prevalence of thyroid disorder with gender distribution, age distribution,
duration of diabetes, BMI, treatment, fasting plasma glucose (FPG), serum triglyceride and
serum cholesterol was then done in diabetic patients. The observations and interpretations
were recorded and results obtained were statistically analyzed.
Results: The prevalence of thyroid dysfunction among type2 diabetic patients was
found to be 13,2%. In the control group, the prevalence of thyroid dysfunction was 6,3%.
There was a significant difference between diabetics and control subjects p= 0,031.The
most frequently TD in type2 diabetic patients was subclinical hypothyroidism (8,3%).
Thyroid dysfunction was significantly correlated with gender (women > man), age < 60
years, FPG > 130mg/dl, TG > 150mg/dl and insulin treatment in type2 diabetic patients.
Conclusion: Screening of thyroid dysfunction shoud be done in all Type2 diabetic
patients.
Heart disease, particularly coronary artery disease is a major cause of
morbidity and mortality among patients with diabetes mellitus .
In addition to the increased clinical incidence of coronary artery disease ,
the extent of coronary arteries st
enosed is also greater among diabetics .
T his study showes that diabetics, compared to non-diabetics ,have a higher
incidence of multiple vessel disease (٨٤٪ vs ٤٨٪) and lower incidence of one
vessel disease .
It also showes that left ventricular function and left ventricular wall
movement are more impaired in diabetics .
يتصف الداء السكري بزيادة الاجهاد التأكسدي، و زيادة تشكل الجذور الحرة مما يسبب
انخفاض فاعلية الجمل المضادة للتأكسد و منها الجمل الإنزيمية: غلوتاتيون بيروكسيداز
و سوبر أوكسيد ديسموتاز . للميتفورمين دور كمضاد للتأكسد فيو يعمل على تفعيل
الإنزيمات السا
بقة .
تمت مقايسة المتثابتات التالية في المصل: الغلوكوز، الكوليستيرول، ثلاثيات الغليسيريد،
و مقايسة الفاعلية الإنزيمية لكل من: الغلوتاتيون بيروكسيداز و السوبر اكسيد ديسموتاز في
الكريات الحمر عند الافراد الاصحاء و مرضى السكري نمط II.
أوضحت الدراسة وجود انخفاضاً في فاعلية هذه الإنزيمات عند السكريين، مقارنة مع
الأفراد الأصحاء، و بينت وجود علاقة قوية و طردية بين تعاطي الميتفورمين و فاعلية كل
من الغلوتاتيون بيروكسيداز و السوبر أوكسيد ديسموتاز.